NR
CTSH icon

Newfound Research’s Cognizant CTSH Stock Holding History

Newfound Research’s Portfolio CTSH Stock Details CTSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$64K Buy
1,110
+443
+66% +$29K 0.16% 98
2022
Q2 		$45K Sell
667
-566
-46% -$43.3K 0.1% 127
2022
Q1 		$111K Sell
1,233
-636
-34% -$55.9K 0.14% 92
2021
Q4 		$166K Buy
1,869
+865
+86% +$69.6K 0.2% 16
2021
Q3 		$75K Buy
1,004
+268
+36% +$19.8K 0.12% 94
2021
Q2 		$51K Buy
+736
New +$54.8K 0.1% 105
2020
Q2 		– Sell
-10
Closed – – 78
2020
Q1 		$0 Hold
10
– – ﹤0.01% 109
2019
Q4 		$1K Sell
10
-5
-33% -$309 ﹤0.01% 99
2019
Q3 		$1K Buy
15
+5
+50% +$316 ﹤0.01% 112
2019
Q2 		$1K Buy
10
+2
+25% +$131 ﹤0.01% 108
2019
Q1 		$1K Buy
8
+2
+33% +$140 ﹤0.01% 106
2018
Q4 		$0 Buy
6
+2
+50% +$139 ﹤0.01% 146
2018
Q3 		$0 Buy
4
+1
+33% +$78 ﹤0.01% 188
2018
Q2 		$0 Hold
3
– – ﹤0.01% 173
2018
Q1 		$0 Buy
+3
New +$237 ﹤0.01% 182

Other funds holding CTSH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Newfound Research's CTSH Position: Q3 2022 in Review

Newfound Research increased its Cognizant (CTSH) stake by 66% in Q3 2022, buying an estimated $29K and bringing the position to 1,110 shares worth $64K. The position accounts for 0.16% of the portfolio, ranked #98.

Newfound Research first reported a position in CTSH in Q1 2018 and has held it in 15 quarters since. The position peaked at $166K in Q4 2021. 888 funds tracked by Wall St. Rank hold CTSH as of Q3 2022.

  • Newfound Research held 1,110 shares of Cognizant worth $64K as of Q3 2022.
  • Newfound Research bought 443 Cognizant shares in Q3 2022, an estimated $29K.
  • Cognizant made up 0.16% of Newfound Research's portfolio in Q3 2022, its #98 holding.
  • Newfound Research first reported a position in Cognizant in Q1 2018 and has held it in 15 quarters since.
  • Newfound Research's Cognizant position peaked at $166K in Q4 2021.
  • 888 funds tracked by Wall St. Rank held Cognizant as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.